H. Gregg Schuler

1.4k total citations
44 papers, 857 citations indexed

About

H. Gregg Schuler is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Surgery. According to data from OpenAlex, H. Gregg Schuler has authored 44 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 11 papers in Physiology and 8 papers in Surgery. Recurrent topics in H. Gregg Schuler's work include Cardiac Ischemia and Reperfusion (7 papers), Metabolism and Genetic Disorders (6 papers) and Connective tissue disorders research (5 papers). H. Gregg Schuler is often cited by papers focused on Cardiac Ischemia and Reperfusion (7 papers), Metabolism and Genetic Disorders (6 papers) and Connective tissue disorders research (5 papers). H. Gregg Schuler collaborates with scholars based in United States, Germany and Belgium. H. Gregg Schuler's co-authors include David R. Larach, John C. Werner, Victor Whitman, Raymond R. Fripp, Piotr K. Janicki, Arthur J. Cronin, Yskert Von Kodolitsch, Allen R. Kunselman, Susan DesHarnais and Raymond E. Sicard and has published in prestigious journals such as Circulation Research, PEDIATRICS and Annals of Neurology.

In The Last Decade

H. Gregg Schuler

41 papers receiving 821 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Gregg Schuler United States 19 267 182 181 164 145 44 857
J. G. Wade Canada 19 267 1.0× 405 2.2× 288 1.6× 104 0.6× 168 1.2× 37 1.1k
Duane K. Rorie United States 20 150 0.6× 473 2.6× 112 0.6× 238 1.5× 168 1.2× 62 1.2k
Lennart Fagraeus United States 16 349 1.3× 232 1.3× 176 1.0× 100 0.6× 88 0.6× 42 874
Joel O. Johnson United States 17 148 0.6× 357 2.0× 160 0.9× 45 0.3× 191 1.3× 36 724
Enrico Camporesi United States 14 97 0.4× 375 2.1× 125 0.7× 164 1.0× 288 2.0× 35 798
D Olthoff Germany 20 324 1.2× 386 2.1× 121 0.7× 168 1.0× 243 1.7× 83 1.2k
Maxim Rachinsky Canada 12 131 0.5× 123 0.7× 54 0.3× 137 0.8× 83 0.6× 21 721
Lionel Dumont Switzerland 16 189 0.7× 446 2.5× 129 0.7× 75 0.5× 473 3.3× 52 1.4k
Keita Ikeda United States 12 234 0.9× 157 0.9× 194 1.1× 104 0.6× 69 0.5× 32 883
M. Hägerdal Sweden 21 116 0.4× 113 0.6× 113 0.6× 170 1.0× 131 0.9× 35 1.1k

Countries citing papers authored by H. Gregg Schuler

Since Specialization
Citations

This map shows the geographic impact of H. Gregg Schuler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Gregg Schuler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Gregg Schuler more than expected).

Fields of papers citing papers by H. Gregg Schuler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Gregg Schuler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Gregg Schuler. The network helps show where H. Gregg Schuler may publish in the future.

Co-authorship network of co-authors of H. Gregg Schuler

This figure shows the co-authorship network connecting the top 25 collaborators of H. Gregg Schuler. A scholar is included among the top collaborators of H. Gregg Schuler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Gregg Schuler. H. Gregg Schuler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Demal, Till, H. Gregg Schuler, Anja Fröhlich, et al.. (2022). Expanding the clinical spectrum of COL2A1 related disorders by a mass like phenotype. Scientific Reports. 12(1). 4489–4489. 4 indexed citations
2.
Фрингс, Андреас, Johannes Steinberg, H. Gregg Schuler, et al.. (2018). Ocular manifestation in Marfan syndrome: corneal biomechanical properties relate to increased systemic score points. Graefe s Archive for Clinical and Experimental Ophthalmology. 256(6). 1159–1163. 11 indexed citations
3.
Hillebrand, Mathias, Dietmar Koschyk, H. Gregg Schuler, et al.. (2017). Diagnostic accuracy study of routine echocardiography for bicuspid aortic valve: a retrospective study and meta-analysis. Cardiovascular Diagnosis and Therapy. 7(4). 367–379. 15 indexed citations
4.
Blankart, Carl Rudolf, Ricarda Milstein, Meike Rybczynski, H. Gregg Schuler, & Yskert Von Kodolitsch. (2016). Economic and care considerations of Marfan syndrome. Expert Review of Pharmacoeconomics & Outcomes Research. 16(5). 591–598. 7 indexed citations
5.
Backer, Julie De, Kerstin Kutsche, Laura Muiño Mosquera, et al.. (2016). Mitral valve prolapse syndrome and MASS phenotype: Stability of aortic dilatation but progression of mitral valve prolapse. IJC Heart & Vasculature. 10. 39–46. 9 indexed citations
6.
Sheikhzadeh, Sara, Julie De Backer, Meike Rybczynski, et al.. (2014). The main pulmonary artery in adults: a controlled multicenter study with assessment of echocardiographic reference values, and the frequency of dilatation and aneurysm in Marfan syndrome. Orphanet Journal of Rare Diseases. 9(1). 203–203. 27 indexed citations
7.
Valentine, Elizabeth, et al.. (2008). The Influence of Neurophysiologic Monitoring on the Management of Pediatric Cardiopulmonary Bypass. ASAIO Journal. 54(5). 467–469. 5 indexed citations
8.
Schuler, H. Gregg, et al.. (2007). Clinical and Laboratory Correlates of Excessive and Persistent Blood Glucose Elevation During Cardiac Surgery in Nondiabetic Patients: A Retrospective Study. Journal of Cardiothoracic and Vascular Anesthesia. 21(6). 843–846. 11 indexed citations
9.
10.
11.
Cronin, Arthur J., T.H. Budinetz, Christopher P. Bonafide, et al.. (2003). Low-dose remifentanil infusion does not impair natural killer cell function in healthy volunteers. British Journal of Anaesthesia. 91(6). 805–809. 37 indexed citations
12.
Schuler, H. Gregg, et al.. (2003). Preservation of the Cortical Somatosensory-Evoked Potential During Dexmedetomidine Infusion in Rats. Anesthesia & Analgesia. 96(4). 1155–1160. 29 indexed citations
13.
Isaacson, Jon E., Matthew T. Moyer, H. Gregg Schuler, & George F. Blackall. (2003). Clinical Associations Between Tinnitus and Chronic Pain. Otolaryngology. 128(5). 706–710. 19 indexed citations
14.
Schuler, H. Gregg, et al.. (1998). FACTORS AFFECTING PATIENT MALLAMPATI SCORE. Anesthesiology. 89(Supplement). 1173A–1173A. 1 indexed citations
15.
Schuler, H. Gregg, et al.. (1995). Comparison of the alteration of cardiac function by sevoflurane, isoflurane, and halothane in the isolated working rat heart. Journal of Cardiothoracic and Vascular Anesthesia. 9(6). 706–712. 22 indexed citations
16.
Larach, David R. & H. Gregg Schuler. (1991). Direct Vasodilation by Sevoflurane, Isoflurane, and Halothane Alters Coronary Flow Reserve in the Isolated Rat Heart. Anesthesiology. 75(2). 268–278. 64 indexed citations
17.
Larach, David R., et al.. (1990). Direct effects of myocardial depressant drugs on coronary vascular tone: anesthetic vasodilation by halothane and isoflurane.. Journal of Pharmacology and Experimental Therapeutics. 254(1). 58–64. 16 indexed citations
18.
Spengler, John D., et al.. (1989). [HLA antigen frequencies in patients with autosomal dominant polycystic kidney degeneration].. PubMed. 82(12). 691–4.
19.
Larach, David R., et al.. (1988). Mass spectrometry for monitoring respiratory and anesthetic gas waveforms in rats. Journal of Applied Physiology. 65(2). 955–963. 7 indexed citations
20.
Werner, John C., et al.. (1983). Fatty acid and glucose utilization in isolated, working fetal pig hearts. American Journal of Physiology-Endocrinology and Metabolism. 245(1). E19–E23. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. G. Wade Breakdown of academic impact, for papers by Duane K. Rorie Breakdown of academic impact, for papers by Lennart Fagraeus Breakdown of academic impact, for papers by Joel O. Johnson Breakdown of academic impact, for papers by Enrico Camporesi Breakdown of academic impact, for papers by D Olthoff Breakdown of academic impact, for papers by Maxim Rachinsky Breakdown of academic impact, for papers by Lionel Dumont Breakdown of academic impact, for papers by Keita Ikeda Breakdown of academic impact, for papers by M. Hägerdal
Rankless by CCL
2026